Senzime AB (SEZI) - Medical Equipment - Deals and Alliances Profile
- GDME82661D
- Pages: 35
- October 2018
- Total Views:1292
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents. Senzime's portfolio of technologies includes bedside systems that enable automated and continuous measurement of biological substances such as glucose and lactate in the blood and tissue fluid and patient-system for peri-operative monitoring of the neuromuscular function in patients undergoing depth of anesthesia. The company's products are used in the areas of medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. Senzime is headquartered in Uppsala, Sweden.
Senzime AB (SEZI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Senzime AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Senzime AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Senzime AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Senzime AB, Medical Equipment, Deal Details 10
Private Equity 10
Senzime to Raise USD3.1 Million in Private Placement of Shares 10
Partnerships 11
Senzime Enters into Licesning Agreement with Fukuda Denshi 11
Senzime Enters into Distribution Agreement with Wardray Premise and LSR Healthcare 12
Equity Offering 13
Senzime Raises USD2.7 Million in Rights Offering of Shares 13
Senzime Raises USD0.3 Million in Private Placement 14
Senzime Raises USD2 Million in Rights Offering of Shares 15
Senzime Raises USD7 Million in Private Placement 16
Senzime Raises USD1.15 Million in Private Placement of Shares 17
Senzime Raises USD2.8 Million in Rights Offering of Shares 18
Senzime to Raise USD1.9 Million in Rights Offering of Shares 19
Senzime Raises USD1 Million in Rights Offering of Common Shares 20
Acquisition 21
Senzime Acquires Acacia Designs for USD10.2 Million 21
Senzime Acquires MD Biomedical 22
Senzime AB-Key Competitors 23
Senzime AB-Key Employees 24
Senzime AB-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 22, 2018: Senzime: Interim report quarter 2, 2018 26
May 08, 2018: Senzime's Interim report January-March 2018 27
Feb 16, 2018: Senzime's Year-end Bulletin 2017 28
Nov 28, 2017: Senzime's Interim report January-September 2017 29
Aug 31, 2017: Senzime's Interim report January-June 2017 30
May 31, 2017: Senzime's Interim report January-March 2017 31
Legal and Regulatory 33
Jun 12, 2017: Senzime receives ISO 13485 certification 33
Feb 07, 2017: Senzime launches new website 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List Of Figure
List of Figures
Senzime AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Senzime AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Senzime AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
Senzime AB, Medical Equipment, Key Facts, 2017 2
Senzime AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Senzime AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Senzime AB, Deals By Market, 2012 to YTD 2018 8
Senzime AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Senzime to Raise USD3.1 Million in Private Placement of Shares 10
Senzime Enters into Licesning Agreement with Fukuda Denshi 11
Senzime Enters into Distribution Agreement with Wardray Premise and LSR Healthcare 12
Senzime Raises USD2.7 Million in Rights Offering of Shares 13
Senzime Raises USD0.3 Million in Private Placement 14
Senzime Raises USD2 Million in Rights Offering of Shares 15
Senzime Raises USD7 Million in Private Placement 16
Senzime Raises USD1.15 Million in Private Placement of Shares 17
Senzime Raises USD2.8 Million in Rights Offering of Shares 18
Senzime to Raise USD1.9 Million in Rights Offering of Shares 19
Senzime Raises USD1 Million in Rights Offering of Common Shares 20
Senzime Acquires Acacia Designs for USD10.2 Million 21
Senzime Acquires MD Biomedical 22
Senzime AB, Key Competitors 23
Senzime AB, Key Employees 24
Senzime AB, Other Locations 25
Senzime AB, Subsidiaries 25
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Senzime AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents. Senzime's portfolio of technologies includes bedside systems that enable automated and continuous measurement of biological substances such as glucose and lactate in the blood and tissue fluid and patient-system for peri-operative monitoring of the neuromuscular function in patients undergoing depth of anesthesia. The company's products are used in the areas of medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. Senzime is headquartered in Uppsala, Sweden.
Senzime AB (SEZI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Senzime AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Senzime AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Senzime AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Senzime AB, Medical Equipment, Deal Details 10
Private Equity 10
Senzime to Raise USD3.1 Million in Private Placement of Shares 10
Partnerships 11
Senzime Enters into Licesning Agreement with Fukuda Denshi 11
Senzime Enters into Distribution Agreement with Wardray Premise and LSR Healthcare 12
Equity Offering 13
Senzime Raises USD2.7 Million in Rights Offering of Shares 13
Senzime Raises USD0.3 Million in Private Placement 14
Senzime Raises USD2 Million in Rights Offering of Shares 15
Senzime Raises USD7 Million in Private Placement 16
Senzime Raises USD1.15 Million in Private Placement of Shares 17
Senzime Raises USD2.8 Million in Rights Offering of Shares 18
Senzime to Raise USD1.9 Million in Rights Offering of Shares 19
Senzime Raises USD1 Million in Rights Offering of Common Shares 20
Acquisition 21
Senzime Acquires Acacia Designs for USD10.2 Million 21
Senzime Acquires MD Biomedical 22
Senzime AB-Key Competitors 23
Senzime AB-Key Employees 24
Senzime AB-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 22, 2018: Senzime: Interim report quarter 2, 2018 26
May 08, 2018: Senzime's Interim report January-March 2018 27
Feb 16, 2018: Senzime's Year-end Bulletin 2017 28
Nov 28, 2017: Senzime's Interim report January-September 2017 29
Aug 31, 2017: Senzime's Interim report January-June 2017 30
May 31, 2017: Senzime's Interim report January-March 2017 31
Legal and Regulatory 33
Jun 12, 2017: Senzime receives ISO 13485 certification 33
Feb 07, 2017: Senzime launches new website 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List Of Figure
List of Figures
Senzime AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Senzime AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Senzime AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
Senzime AB, Medical Equipment, Key Facts, 2017 2
Senzime AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Senzime AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Senzime AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Senzime AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Senzime AB, Deals By Market, 2012 to YTD 2018 8
Senzime AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Senzime to Raise USD3.1 Million in Private Placement of Shares 10
Senzime Enters into Licesning Agreement with Fukuda Denshi 11
Senzime Enters into Distribution Agreement with Wardray Premise and LSR Healthcare 12
Senzime Raises USD2.7 Million in Rights Offering of Shares 13
Senzime Raises USD0.3 Million in Private Placement 14
Senzime Raises USD2 Million in Rights Offering of Shares 15
Senzime Raises USD7 Million in Private Placement 16
Senzime Raises USD1.15 Million in Private Placement of Shares 17
Senzime Raises USD2.8 Million in Rights Offering of Shares 18
Senzime to Raise USD1.9 Million in Rights Offering of Shares 19
Senzime Raises USD1 Million in Rights Offering of Common Shares 20
Senzime Acquires Acacia Designs for USD10.2 Million 21
Senzime Acquires MD Biomedical 22
Senzime AB, Key Competitors 23
Senzime AB, Key Employees 24
Senzime AB, Other Locations 25
Senzime AB, Subsidiaries 25
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Senzime AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
: +91 9015378249
Related Reports
Page 99 | 
April 2022
Page 47 | March 2022
Page 47 | February 2022
Page 91 | January 2022
Page 89 | December 2021